First-in-human phase I dose escalation study of the...

European Journal of Cancer 2016 / 12 Vol. 69

First-in-human phase I dose escalation study of the Bromodomain and Extra-Terminal motif (BET) inhibitor BAY 1238097 in subjects with advanced malignancies

Postel-Vinay, S., Herbschleb, K., Massard, C., Woodcock, V., Ocker, M., Wilkinson, G., Walter, A., Ewerton, F., Poelman, M., Middleton, M., Soria, J.C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
69
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)32620-x
Date:
December, 2016
File:
PDF, 51 KB
english, 2016
Conversion to is in progress
Conversion to is failed